Lenore M Snowden Opalak, MD | |
4 Corporate Dr, Suite 394, Shelton, CT 06484-6211 | |
(203) 225-0375 | |
(203) 225-0376 |
Full Name | Lenore M Snowden Opalak |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 4 Corporate Dr, Shelton, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033163605 | NPI | - | NPPES |
001277755 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 027775 (Connecticut) | Primary |
Entity Name | Northeast Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Daylight saving time can wreak havoc on the millions of people already affected by sleep problems, but a few simple sleep habits can make all the difference this March 10.
Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs.
Researchers in the U.S. have found that jet lag or rotating shift work shortens the lifespan in mice and they say it raises concerns for humans affected by time disruption.
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.
› Verified 2 days ago
Entity Name | My Catholic Doctor Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396201307 PECOS PAC ID: 7214367101 Enrollment ID: O20200428000923 |
News Archive
Daylight saving time can wreak havoc on the millions of people already affected by sleep problems, but a few simple sleep habits can make all the difference this March 10.
Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs.
Researchers in the U.S. have found that jet lag or rotating shift work shortens the lifespan in mice and they say it raises concerns for humans affected by time disruption.
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Lenore M Snowden Opalak, MD 4 Corporate Dr, Suite 394, Shelton, CT 06484-6211 Ph: (203) 225-0375 | Lenore M Snowden Opalak, MD 4 Corporate Dr, Suite 394, Shelton, CT 06484-6211 Ph: (203) 225-0375 |
News Archive
Daylight saving time can wreak havoc on the millions of people already affected by sleep problems, but a few simple sleep habits can make all the difference this March 10.
Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs.
Researchers in the U.S. have found that jet lag or rotating shift work shortens the lifespan in mice and they say it raises concerns for humans affected by time disruption.
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.
› Verified 2 days ago
Stephen R Woodworth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Ivy Brook Rd, Suite 205, Shelton, CT 06484 Phone: 203-922-9466 Fax: 203-922-9477 | |
Dr. Piotr Waldemar Baginski, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr, Suite 283, Shelton, CT 06484 Phone: 203-944-9775 Fax: 203-944-9964 | |
Dr. Murugesapillai Koneswaran, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 21 Huntington Plaza, Shelton, CT 06484 Phone: 203-929-6358 Fax: 203-929-3826 | |
Dr. Lavanya Bellumkonda, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr Ste 100, Shelton, CT 06484 Phone: 203-929-9799 | |
Joseph Thomas Coyne, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd, Ste 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
John Farens, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 |